Text

Authorised allergen products for intracutaneous testing may no longer be available in Germany

---

Abstract Background:Beside the skin prick test, the intracu-taneous test represents the most important skin test method for detecting type-1 allergies. With the in-corporation of European directives into national law, test allergens used for allergy diagnosis are
deemed medicinal products within the meaning of the German Medicinal Products Act (Arzneimittel-gesetz) and therefore require marketing authorisa-tion for distribution in Germany. ­e high costs of acquiring and maintaining these authorisations have lead to no new €nished intracutaneous test products being authorized in Germany for more than 20 years. Instead, most manufacturers have
voluntarily withdrawn their existing marketing au-thorisations for intracutaneous test extracts. ­e last manufacturer to o†er approved €nished aller-gen products for intracutaneous tests recently an-nounced that it would now cease production and distribution of these solutions.Methods:Research on the current European and German legislation; selective literature search in Medline, including national and international guidelines and Cochrane meta-analyses; licensing information on the Paul-Ehrlich-Institute home-page (www.pei.de) as well as in the Bundesanzeiger (Federal Gazette).

---

Ketersediaan

Tidak ada salinan data

Informasi Detail

Judul Seri

-

No. Panggil

Artikel

Penerbit

: Springer., 2015

Deskripsi Fisik

-

Bahasa

English

ISBN/ISSN

DOI: 10.1007/s40629-

Klasifikasi

NONE

Tipe Isi

-

Tipe Media

-

Tipe Pembawa

-

Edisi

Allergo J Int 2015; 24: 84–93

Subjek

Medicine
Allergen
Intracutaneous

Info Detail Spesifik

-

Pernyataan Tanggungjawab

-

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus masuk sebelum memberikan komentar